Zydus Lifesciences to Acquire Assertio Holdings for $166.4 Million
Assertio Holdings, Inc. (ASRT) entered a merger agreement on May 13, 2026, to be acquired by Zydus Lifesciences for $166.4 million, after terminating its earlier merger with Garda…
Written byAsif SuriaSource: InsideArbitrage
Assertio Holdings, Inc. (ASRT) entered a merger agreement on May 13, 2026, to be acquired by Zydus Lifesciences for $166.4 million, after terminating its earlier merger with Garda Therapeutics. Deal Structure: Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences, will commence a tender offer to acquire all outstanding shares of Assertio common stock for $23.5